Safety Study of Capecitabine With Radiation in Elderly Rectal Cancer
Status:
Completed
Trial end date:
2014-05-01
Target enrollment:
Participant gender:
Summary
This phase I study is designed to determine the maximum tolerant dose of capecitabine when
used in preoperative concurrent chemo-radiation for locally advanced rectal patients over 75
years old.